Significance of LL‐37 on Immunomodulation and Disease Outcome

Binbin Yang(Griffith University), David A. Good(Griffith University), Tamim Mosaiab(Griffith University), Wei Liu(Griffith University), Guoying Ni(Griffith University), Jasmine Kaur(Griffith University), Xiaosong Liu(University of the Sunshine Coast), Calvin Jessop(Griffith University), Lu Yang(Griffith University), Rushdi Fadhil(Griffith University), Zhengjun Yi(Weifang Medical University), Ming Wei(Griffith University)
BioMed Research International
January 1, 2020
Cited by 129Open Access
Full Text

Abstract

LL-37, also called cathelicidin, is an important part of the human immune system, which can resist various pathogens. A plethora of experiments have demonstrated that it has the multifunctional effects of immune regulation, in addition to antimicrobial activity. Recently, there have been increasing interest in its immune function. It was found that LL-37 can have two distinct functions in different tissues and different microenvironments. Thus, it is necessary to investigate LL-37 immune functions from the two sides of the same coin. On the one side, LL-37 promotes inflammation and immune response and exerts its anti-infective and antitumor effects; on the other side, it has the ability to inhibit inflammation and promote carcinogenesis. This review presents a brief summary of its expression, structure, and immunomodulatory effects as well as brief discussions on the role of this small peptide as a key factor in the development and treatment of various inflammation-related diseases and cancers.


Related Papers

No related papers found

Powered by citation graph analysis